Limonene

1. INCI & CAS

INCI: Limonene · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Limonene is carried as a named cosmetic ingredient for this SKU. Identity, assay and impurities are confirmed on the supplier TDS and COA. This page does not invent a CAS or a drug effect.

3. Typical use levels (formulation guide)

• Refer to the supplier TDS to establish a suitable level in the finished formula.

Check the supplier TDS for solvent, temperature and pH.

4. Regulatory sources & global compliance

• Use CosIng's information on Limonene as a reference, then verify the specific grade and intended use under market rules.
• An EU-market cosmetic under Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Limonene rather than for an ingredient name alone.
• Review the documentation for the actual Limonene grade and the filing requirements for the target market.

5. Safety & risk assessment

This entry provides guidance for cosmetic use only; it provides no evidence that a drug or OTC monograph applies and patch and stability testing remain part of finished-product review.

6. Stability & packaging

Keep bulk supplies closed, cool, and protected from sunlight; evaluate packaging against the formula's susceptibility to oxidation; follow with stability and packaging checks on the confirmed batch.

7. Claims language (Do / Don’t)

• Names Limonene as a cosmetic ingredient on this SKU

• This formulation entry cannot verify therapeutic outcomes, clinical cures, or a certification the finished SKU does not hold.
• The available details for Limonene cannot verify whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

As a polyol humectant, glycerin is used in cosmetic emulsions, gels, and washes. The recorded percentage is not a measured batch value.

3. Typical use levels (formulation guide)

• For gels and serums, the reference gives 3–8% as a formulation guide.
• The level shown for creams is 2–5%.
• The stated reference for rinse-off is 2–4%.

Add Glycerin in the water phase without melting it first.

4. Regulatory sources & global compliance

• A CosIng listing for Glycerin provides ingredient information, not approval of a supplied grade or finished product.
• For an EU-market product, Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Glycerin in the final product context.
• Match the selected Glycerin material to its supplier TDS and check the filing list for the market of sale.

5. Safety & risk assessment

Treat the listed amount as cosmetic-development guidance; it does not qualify a finished product as a drug or OTC product so assess patch response and stability in the final formula.

6. Stability & packaging

Keep the ingredient in cool, closed bulk storage away from sunlight; for oxidation-sensitive formulas, consider an airless or pump pack; assess the confirmed formula for stability and package compatibility.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Glycerin highlights humectant function.

• The available ingredient details does not substantiate therapeutic effects, curative outcomes, or unsupported certification statements.
• The documented facts for Glycerin cannot establish whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Typical use levels (formulation guide)

• Formulation guidance for gel-creams: 2–6%.
• Dry oils may use the guide range 10–30% as a formulation guide.
• The stated reference for balms is 5–15% in this reference.

Add Squalane through the oil phase; no additional wax-processing shear step is called for.

4. Regulatory sources & global compliance

• CosIng provides reference information for Squalane; confirm the specific grade and intended use against market requirements.
• EU market placement under Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Squalane at the level of the finished cosmetic product.
• Compare the received Squalane material with its supplier specification and review destination-market filing needs.

5. Safety & risk assessment

This entry provides guidance for cosmetic use only; it does not establish drug approval or OTC-monograph status and the completed cosmetic needs its own patch and stability checks.

6. Stability & packaging

Keep the bulk container closed and shaded in a cool area; review airless or pump options if oxidation presents a concern; assess the confirmed formula for stability and package compatibility.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Squalane highlights a light-emollient role.

• The listed information does not demonstrate claims of drug action or cure, or a product certification outside the supporting records.
• The documented facts for Squalane cannot verify whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.